German protein research firm Protagen has secured €10m ($12.8m) from a second round of financing in order to fund the development of diagnostic marker proteins. New investor NRW.BANK joined MIG Fonds, S-Capital Dortmund, S-Venture Capital Dortmund and KfW in the round. ...
Please Login to read the full article.
